510(k) for EP MedSystems' SilverFlex technology:
This article was originally published in Clinica
EP MedSystems has received US FDA clearance for its new range of silver-coated electrophysiology catheters used in the diagnosis and treatment of cardiac disorders. The Mount Arlington, New Jersey-based company says the advantages of the SilverFlex technology, which was used for coating the catheter tube with a very thin layer of silver, includes flexibility, conductivity and a manufacturing cost savings of up to 50% compared with standard hard metal electrodes. In addition, the technology allows a large number of electrodes to be placed on the catheter.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.